Simona King - 23 Aug 2021 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Chief Financial Officer
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
23 Aug 2021
Net transactions value
$0
Form type
4
Filing time
25 Aug 2021, 18:44:46 UTC
Next filing
14 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Employee Stock Option (Right to Buy) Award $0 +360,000 $0.000000 360,000 23 Aug 2021 Common Stock 360,000 $11.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on August 23, 2022, then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on August 23, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.